A detailed history of Sprucegrove Investment Management LTD transactions in Johnson & Johnson stock. As of the latest transaction made, Sprucegrove Investment Management LTD holds 109,135 shares of JNJ stock, worth $16.9 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares
109,135
Previous 109,535 0.37%
Holding current value
$16.9 Million
Previous $16 Million 10.48%
% of portfolio
1.2%
Previous 1.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$145.48 - $167.38 $58,191 - $66,952
-400 Reduced 0.37%
109,135 $17.7 Million
Q2 2024

Aug 12, 2024

BUY
$144.38 - $157.78 $187,694 - $205,114
1,300 Added 1.2%
109,535 $16 Million
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $8.34 Million - $8.74 Million
53,700 Added 98.47%
108,235 $17.1 Million
Q4 2023

Jan 29, 2024

BUY
$145.6 - $158.88 $189,280 - $206,544
1,300 Added 2.44%
54,535 $8.55 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $57,471 - $64,383
-369 Reduced 0.69%
53,235 $8.29 Million
Q2 2023

Aug 11, 2023

SELL
$154.35 - $166.11 $1.19 Million - $1.28 Million
-7,696 Reduced 12.55%
53,604 $8.87 Million
Q1 2023

May 10, 2023

SELL
$151.05 - $180.26 $151,050 - $180,260
-1,000 Reduced 1.61%
61,300 $9.5 Million
Q4 2022

Feb 08, 2023

SELL
$160.2 - $179.79 $1.83 Million - $2.05 Million
-11,400 Reduced 15.47%
62,300 $11 Million
Q3 2022

Nov 09, 2022

SELL
$161.33 - $179.52 $5.31 Million - $5.91 Million
-32,900 Reduced 30.86%
73,700 $12 Million
Q2 2022

Aug 11, 2022

SELL
$168.19 - $186.01 $10.2 Million - $11.3 Million
-60,800 Reduced 36.32%
106,600 $18.9 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $14.6 Million - $16.5 Million
-92,100 Reduced 35.49%
167,400 $29.7 Million
Q4 2021

Feb 10, 2022

SELL
$155.93 - $173.01 $3.85 Million - $4.27 Million
-24,700 Reduced 8.69%
259,500 $44.4 Million
Q3 2021

Nov 08, 2021

BUY
$161.5 - $179.47 $2.18 Million - $2.42 Million
13,500 Added 4.99%
284,200 $45.9 Million
Q2 2021

Aug 10, 2021

SELL
$159.48 - $171.07 $303,012 - $325,033
-1,900 Reduced 0.7%
270,700 $44.6 Million
Q1 2021

May 12, 2021

BUY
$153.07 - $170.48 $520,438 - $579,632
3,400 Added 1.26%
272,600 $44.8 Million
Q4 2020

Feb 05, 2021

BUY
$137.11 - $157.38 $20.6 Million - $23.7 Million
150,500 Added 126.79%
269,200 $42.4 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $4.67 Million - $5.12 Million
33,300 Added 38.99%
118,700 $17.7 Million
Q2 2020

Aug 13, 2020

SELL
$128.81 - $155.51 $4.64 Million - $5.6 Million
-36,000 Reduced 29.65%
85,400 $12 Million
Q1 2020

May 15, 2020

BUY
$111.14 - $153.99 $422,332 - $585,162
3,800 Added 3.23%
121,400 $15.9 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $171,615 - $197,108
1,346 Added 1.16%
117,600 $17.2 Million
Q3 2019

Nov 12, 2019

BUY
$126.95 - $142.14 $311,535 - $348,811
2,454 Added 2.16%
116,254 $15 Million
Q2 2019

Aug 12, 2019

SELL
$131.15 - $144.24 $1.63 Million - $1.79 Million
-12,400 Reduced 9.83%
113,800 $15.9 Million
Q1 2019

May 07, 2019

SELL
$125.72 - $139.79 $4.15 Million - $4.61 Million
-33,000 Reduced 20.73%
126,200 $17.6 Million
Q4 2018

Feb 08, 2019

SELL
$122.84 - $147.84 $1.74 Million - $2.1 Million
-14,200 Reduced 8.19%
159,200 $20.5 Million
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $389,056 - $457,216
3,200 Added 1.88%
173,400 $24 Million
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $1.21 Million - $1.33 Million
-10,100 Reduced 5.6%
170,200 $20.7 Million
Q1 2018

May 11, 2018

SELL
$125.1 - $148.14 $250,200 - $296,280
-2,000 Reduced 1.1%
180,300 $23.1 Million
Q4 2017

Feb 09, 2018

SELL
$131.22 - $143.62 $5.2 Million - $5.69 Million
-39,600 Reduced 17.85%
182,300 $25.5 Million
Q3 2017

Nov 08, 2017

BUY
$129.47 - $135.38 $28.7 Million - $30 Million
221,900
221,900 $28.8 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Sprucegrove Investment Management LTD Portfolio

Follow Sprucegrove Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sprucegrove Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sprucegrove Investment Management LTD with notifications on news.